1 Result(s)

Article

¹⁸F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib

¹⁸F-fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) are useful imaging modalities for evaluating tumor progression and treatment responses in genetically engineered mouse m....

K Duncan, T R Rosean, V S Tompkins, A Olivier, R Sompallae, F Zhan… in Blood Cancer Journal (2013)